Opinion: Don’t Forget About Antibiotics
January 9, 2020
U.S. lawmakers should “consider antibiotics as a special case” to provide relief to an embattled antibiotic pipeline, Pew Charitable Trusts’ Allan Coukell writes in an opinion piece published on STAT.
“More than 90% of antibiotics in the pipeline today are being developed by small companies like these, not by the pharmaceutical giants that once dominated the field,” Coukell writes. “And with antibiotic prices low and profit margins narrow, many small companies just can’t stay afloat.”
To read the full article, click here.
